Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Launches
Pharma
Orzeyful gets off to races in US with 'lighter' DEA schedule
With a positive classification from the DEA paving the way for Orzeyful’s U.S. launch, Takeda is charting new territory in narcolepsy treatment.
Fraiser Kansteiner
Nov 12, 2026 11:16am
The Oral GLP-1 Tracker: Foundayo reaches new Rx heights
Nov 6, 2026 11:00am
$200M in 5 weeks: Behind RevMed's 'eye-popping' Rasonque debut
Nov 5, 2026 11:11am
GSK talks through Hibsago launch as it reports out mixed Q3
Oct 28, 2026 11:05am
Vabysmo shows signs of recovery as Roche gears up for busy 2027
Oct 22, 2026 11:20am
National Fragility Index spotlights drug supply-chain problems
Oct 7, 2026 10:15am
